Barton Blackorby, MD
Retina Specialist · Brentwood, MONPI 1477825875
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Genentech USA, Inc. accounts for 79.8% of it on its own, with 16 other manufacturers making up the rest. 2025 is the largest year on record at $22,101, more than ten times the $744 reported in 2019.
Across 119 payments — averaging $263.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$25K
- Bausch & Lomb Americas Inc.$2K
- Dutch Ophthalmic, USA$1K
- AbbVie$629
- Regeneron Healthcare Solutions, Inc.$612
- Astellas Pharma US Inc$443
- plus $2K from 11 others
What the payments were for
- Consulting fees$3,11010%
- Speaking & faculty fees$18,62059%
- Grants$2,0006%
- Travel & lodging$2,6338%
- Food & beverage$4,94616%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 40 | $24,992 |
| Bausch & Lomb Americas Inc. | 2 | $2,018 |
| Dutch Ophthalmic, USA | 4 | $1,074 |
| AbbVie(2 entities) | 19 | $629 |
| Regeneron Healthcare Solutions, Inc. | 11 | $612 |
| Astellas Pharma US Inc | 13 | $443 |
| Genentech, Inc. | 6 | $389 |
| Harrow Eye, LLC | 4 | $204 |
| Novartis | 4 | $200 |
| Alimera Sciences, Inc. | 4 | $185 |
| Apellis Pharmaceuticals, Inc. | 4 | $164 |
| Carl Zeiss Meditec USA, Inc. | 1 | $152 |
| Alcon | 2 | $114 |
| Carl Zeiss Meditec, Inc. | 1 | $72 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $28 |
| LKC Technologies, Inc. | 1 | $19 |
| Rxsight Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUSVIMO$24,757
- EVA, combined machine$840
- TISSUEBLUE$840
- EYLEA HD$265
- OZURDEX$248
- VABYSMO$150
- EYLEA$125
- IHEEZO$125
- TRIESENCE$125
- Iluvien$125
- Izervay$125
- Lucentis$124
- EVA Ophthalmic Surgical System$122
How this compares
$31,310 in reported general payments places this provider in the 85th percentile of 45 retina specialist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 213 | $7,704 |
| Ketorolac Tromethamine | 104 | $2,212 |
| Brimonidine Tartrate | 63 | $1,738 |
| MoxifloxacinMoxifloxacin Hcl | 38 | $892 |
| Ofloxacin | 51 | $564 |
| Latanoprost | 20 | $264 |
| Dorzolamide Hcl | 12 | $231 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 17 | $186 |
| Timolol Maleate | 11 | $91 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Brentwood
- Kevin BlinderBrentwood$333K
- Sabin DangBrentwood$174K
- Athanasios PapakostasBrentwood$85K
- Alia DurraniBrentwood$53K
- Ollya FromalBrentwood$14K
- Nicholas IafeBrentwood$9K
- Dillan PatelBrentwood$5K
- Bradley SmithBrentwood$5K
- William AndersonBrentwood$4K
- Prithvi BomdicaBrentwood$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.